Dissecting the mechanism of herpesvirus genome packaging
剖析疱疹病毒基因组包装机制
基本信息
- 批准号:10509325
- 负责人:
- 金额:$ 50.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-25 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptedAfrica South of the SaharaAntiviral AgentsAreaAwardBacteriophagesBehaviorBiochemicalBiochemistryBiological AssayBiologyBiophysicsCancer EtiologyCapsidChargeComplexCongenital AbnormalityCoupledDNA VirusesDevelopmentDiseaseDissectionDrug TargetingEvolutionFDA approvedFoundationsGenomeGoalsHIVHerpes LabialisHerpes encephalitisHerpesviridaeHigh PrevalenceHomologous GeneHumanHuman Herpesvirus 8Immunocompromised HostIn VitroIndividualInfectionInvestmentsKaposi SarcomaLabelLeadLifeMalignant NeoplasmsMass Spectrum AnalysisMethodologyMethodsMicroscopyMolecularMolecular MotorsMolecular VirologyMonitorMotorMutagenesisNucleic Acid BindingOncogenicPharmaceutical PreparationsPositioning AttributeProcessProteinsProteomicsRegulationResearch PersonnelResourcesRoleStructureSystemTailTechniquesTestingTimeViralViral GenomeViral PackagingViral ProteinsVirusVirus ReplicationVisionWorkbasebiophysical propertiesdrug discoveryhigh rewardhigh riskhuman pathogenin vivoinhibitorinnovationinsightinterestmutation screeningneonatenew therapeutic targetnovelpathogenprogramsreconstitutionresistance mutationscaffoldstructural biologysuccessterminasevirology
项目摘要
PROJECT SUMMARY
Human herpesviruses can cause congenital birth defects in neonates and a wide range of disease in humans,
with particularly devastating effects in immunocompromised individuals. Kaposi's sarcoma-associated
herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma and other cancers, with high prevalence in sub-
Saharan Africa. There is no cure for any herpesvirus; most existing antivirals target a single viral process and
can lead to resistance mutations. The recent development of a herpesviral packaging inhibitor highlights the
viral genome packaging machinery as an attractive target for novel antivirals. The herpesviral packaging
machinery is conceptually similar to that of bacteriophages, yet it has additional complexities that include
factors of unknown function. In this proposal, I outline my vision to understand the molecular mechanism of
herpesvirus packaging. I will determine the function of an essential factor in herpesvirus packaging that has
long evaded mechanistic dissection using state-of-the-art proteomics and microscopy approaches. I will also
develop a new strategy to apply deep mutational scanning approaches to herpesviral proteins. In parallel, I will
determine the structure of the KSHV terminase, the viral molecular motor that packages the viral genome into
the nascent capsid. I will then reconstitute the essential components of the KSHV packaging machinery and
use these to develop an in vitro packaging assay. This assay will be leveraged to screen for new antivirals and
determine the molecular underpinnings of existing drugs that target the packaging machinery. The proposed
studies will build a foundation to address long-standing, fundamental questions in DNA virus packaging and
understand the mechanism of anti-herpesvirals.
项目摘要
人类疱疹病毒可能会导致新生儿的先天性先天性缺陷和人类多种疾病,
在免疫功能低下的个体中具有特别破坏性的影响。卡波西与肉瘤相关
疱疹病毒(KSHV)是Kaposi肉瘤和其他癌症的致病药物,在子 -
撒哈拉非洲。无法治愈任何疱疹病毒。大多数现有的抗病毒药针对单个病毒过程,并且
可能导致抗性突变。疱疹病毒包装抑制剂的最新发展突出了
病毒基因组包装机制是新型抗病毒药的有吸引力的目标。疱疹病毒包装
机械在概念上与噬菌体相似,但它具有其他复杂性,包括
功能未知因素。在此提案中,我概述了理解分子机制的愿景
疱疹病毒包装。我将确定具有疱疹病毒包装中重要因素的功能
长期使用最先进的蛋白质组学和显微镜方法逃避的机械剖析。我也会
制定一种新策略,将深层突变扫描方法应用于疱疹病毒蛋白。同时,我会
确定KSHV末端酶的结构,这是将病毒基因组包装到的病毒分子运动
新生的衣壳。然后,我将重建KSHV包装机械的基本组件,并
使用这些来开发体外包装测定法。该测定法将用于筛选新的抗病毒药和
确定针对包装机械的现有药物的分子基础。提议
研究将建立一个基础,以解决长期存在的DNA病毒包装中的基本问题和
了解抗赫普病毒的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Allison Louise Didychuk其他文献
Allison Louise Didychuk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Adapting and Piloting an Evidence-based Intervention to Improve Hypertension Care among Tanzanians Living with HIV
调整和试点循证干预措施以改善坦桑尼亚艾滋病毒感染者的高血压护理
- 批准号:
10750666 - 财政年份:2023
- 资助金额:
$ 50.25万 - 项目类别:
Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa
开发具有区域代表性的风险评估工具,以确定撒哈拉以南非洲地区感染艾滋病毒风险最高的男性
- 批准号:
10762645 - 财政年份:2023
- 资助金额:
$ 50.25万 - 项目类别:
Investigating the impact of preference-concordant differentiated service delivery for HIV
调查偏好一致的差异化服务提供对艾滋病毒的影响
- 批准号:
10619804 - 财政年份:2023
- 资助金额:
$ 50.25万 - 项目类别:
An interactive, narrative intervention to address the mental health treatment gap among young people living with HIV in Nigeria
一种互动式叙事干预措施,旨在解决尼日利亚艾滋病毒感染者年轻人的心理健康治疗差距
- 批准号:
10914342 - 财政年份:2023
- 资助金额:
$ 50.25万 - 项目类别:
Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
加强肯尼亚艾滋病毒阳性女性的宫颈癌筛查采用和治疗联系 (eCASCADE-Kenya)
- 批准号:
10738134 - 财政年份:2023
- 资助金额:
$ 50.25万 - 项目类别: